These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18985539)

  • 21. Substance P receptor expression in patients with inflammatory bowel disease. Determination by three different techniques, i.e., storage phosphor autoradiography, RT-PCR and immunohistochemistry.
    ter Beek WP; Biemond I; Muller ES; van den Berg M; Lamers CB
    Neuropeptides; 2007 Oct; 41(5):301-6. PubMed ID: 17602742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity.
    Liu Z; Yadav PK; Xu X; Su J; Chen C; Tang M; Lin H; Yu J; Qian J; Yang PC; Wang X
    J Leukoc Biol; 2011 Apr; 89(4):597-606. PubMed ID: 21227898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis.
    Török HP; Glas J; Tonenchi L; Mussack T; Folwaczny C
    Clin Immunol; 2004 Jul; 112(1):85-91. PubMed ID: 15207785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of interleukin-12 receptor beta(2) on lamina propria mononuclear cells of patients with active Crohn's disease.
    Stallmach A; Marth T; Adrian N; Wittig BM; Ecker KW; Schilling M; Zeitz M
    Int J Colorectal Dis; 2002 Sep; 17(5):303-10. PubMed ID: 12172923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single nucleotide polymorphisms in C-type lectin genes, clustered in the IBD2 and IBD6 susceptibility loci, may play a role in the pathogenesis of inflammatory bowel diseases.
    Wolfkamp SC; Verstege MI; Vogels EW; Meisner S; Verseijden C; Stokkers PC; te Velde AA
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):965-70. PubMed ID: 22664939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease.
    Danese S; Sgambato A; Papa A; Scaldaferri F; Pola R; Sans M; Lovecchio M; Gasbarrini G; Cittadini A; Gasbarrini A
    Am J Gastroenterol; 2005 Apr; 100(4):886-95. PubMed ID: 15784037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased Toll-interacting protein and peroxisome proliferator-activated receptor γ are associated with increased expression of Toll-like receptors in colon carcinogenesis.
    Pimentel-Nunes P; Gonçalves N; Boal-Carvalho I; Afonso L; Lopes P; Roncon-Albuquerque R; Soares JB; Cardoso E; Henrique R; Moreira-Dias L; Dinis-Ribeiro M; Leite-Moreira AF
    J Clin Pathol; 2012 Apr; 65(4):302-8. PubMed ID: 22228906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal alkaline phosphatase in the colonic mucosa of children with inflammatory bowel disease.
    Molnár K; Vannay A; Szebeni B; Bánki NF; Sziksz E; Cseh A; Győrffy H; Lakatos PL; Papp M; Arató A; Veres G
    World J Gastroenterol; 2012 Jul; 18(25):3254-9. PubMed ID: 22783049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays.
    Costello CM; Mah N; Häsler R; Rosenstiel P; Waetzig GH; Hahn A; Lu T; Gurbuz Y; Nikolaus S; Albrecht M; Hampe J; Lucius R; Klöppel G; Eickhoff H; Lehrach H; Lengauer T; Schreiber S
    PLoS Med; 2005 Aug; 2(8):e199. PubMed ID: 16107186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease.
    Uhlig HH
    Gut; 2013 Dec; 62(12):1795-805. PubMed ID: 24203055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced expression of CXCL10 in inflammatory bowel disease: potential role of mucosal Toll-like receptor 3 stimulation.
    Ostvik AE; Granlund AV; Bugge M; Nilsen NJ; Torp SH; Waldum HL; Damås JK; Espevik T; Sandvik AK
    Inflamm Bowel Dis; 2013 Feb; 19(2):265-74. PubMed ID: 22685032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression of tumor necrosis factor receptor associated-factor (TRAF)-1 and TRAF-2 in inflammatory bowel disease.
    Qiao YQ; Shen J; Gu Y; Tong JL; Xu XT; Huang ML; Ran ZH
    J Dig Dis; 2013 May; 14(5):244-50. PubMed ID: 23414308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histamine Receptor 2 is Required to Suppress Innate Immune Responses to Bacterial Ligands in Patients with Inflammatory Bowel Disease.
    Smolinska S; Groeger D; Perez NR; Schiavi E; Ferstl R; Frei R; Konieczna P; Akdis CA; Jutel M; OʼMahony L
    Inflamm Bowel Dis; 2016 Jul; 22(7):1575-86. PubMed ID: 27271490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptor expression in crypt epithelial cells, putative stem cells and intestinal myofibroblasts isolated from controls and patients with inflammatory bowel disease.
    Brown M; Hughes KR; Moossavi S; Robins A; Mahida YR
    Clin Exp Immunol; 2014 Oct; 178(1):28-39. PubMed ID: 24828022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA Methylation Profiling in Inflammatory Bowel Disease Provides New Insights into Disease Pathogenesis.
    McDermott E; Ryan EJ; Tosetto M; Gibson D; Burrage J; Keegan D; Byrne K; Crowe E; Sexton G; Malone K; Harris RA; Kellermayer R; Mill J; Cullen G; Doherty GA; Mulcahy H; Murphy TM
    J Crohns Colitis; 2016 Jan; 10(1):77-86. PubMed ID: 26419460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells.
    Skovdahl HK; Granlund Av; Østvik AE; Bruland T; Bakke I; Torp SH; Damås JK; Sandvik AK
    PLoS One; 2015; 10(11):e0141710. PubMed ID: 26536229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Necroptosis is active in children with inflammatory bowel disease and contributes to heighten intestinal inflammation.
    Pierdomenico M; Negroni A; Stronati L; Vitali R; Prete E; Bertin J; Gough PJ; Aloi M; Cucchiara S
    Am J Gastroenterol; 2014 Feb; 109(2):279-87. PubMed ID: 24322838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal toll-like receptor 3-dependent synthesis of complement factor B and systemic complement activation in inflammatory bowel disease.
    Ostvik AE; Granlund Av; Gustafsson BI; Torp SH; Espevik T; Mollnes TE; Damås JK; Sandvik AK
    Inflamm Bowel Dis; 2014 Jun; 20(6):995-1003. PubMed ID: 24739633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease.
    Szebeni B; Veres G; Dezsõfi A; Rusai K; Vannay A; Mraz M; Majorova E; Arató A
    Clin Exp Immunol; 2008 Jan; 151(1):34-41. PubMed ID: 17991289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.